Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

  • johngunn51 johngunn51 Apr 13, 2013 6:32 PM Flag

    Company's tests have little commercial value

    They are not selling well, I don't believe they will ever sell well enough for the company to have a profitable quarter, let alone year. They are too expensive for what they do and lower priced newer technology diagnostics will make Rosetta's situation untenable over time. If they don't use some of the money that's left from the 4 bail-outs, er I mean financings, to get into another business, they're done. The management and insiders will milk the 22 mil that's left and live high on the hog and then say see ya. You have to be a moron to buy stock in this company at this point. I was one, I lost some money, my cost basis was 4.33, but I believe I did the right thing, better late than never

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ROSG
3.56+0.120(+3.49%)May 5 3:59 PMEDT